Article: Five Prime Therapeutics to Subscribe to a BioExpress Custom Suite from Gene Logic.

Business Editors/Health/Medical Writers

BIOWIRE2K

GAITHERSBURG, Md.--(BUSINESS WIRE)--July 7, 2003

Gene Logic Inc. (Nasdaq:GLGC) today announced that Five Prime Therapeutics, Inc. ("Five Prime"), a privately held biopharmaceutical company, has subscribed to a BioExpress(TM) Custom Suite. Five Prime will apply the Custom Suite as an added dimension to their proprietary Pharmanome(TM)-based therapeutics discovery efforts. Financial details of the multiyear subscription agreement were not disclosed.

Under the subscription agreement, Five Prime researchers will access a customized information product comprised of select sets of gene ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!